维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

11篇 您的检索式：作者名="David YH"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis显示文摘	David SCH Teresa YH Thomas L	2002	Med Sci Monit2002，8，5：	1
	2	Propofo exerts protective effects on the acute lung injury in duced by endotoxin in rats显示文摘	Chu CH David Liu D Hsu YH	2007	Pulm Pharmacol T her2007，20，5：	1
	3	Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats 显示文摘	Chu CH David Liu D Hsu YH	2007	Pulm Pharmacol Ther2007，20，5：	1
	4	Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats显示文摘	Chu CH David LD Hsu YH	2007	Pulm Pharmacol Ther2007，20，5：	1
	5	Catheter ablation for atrial fibrillation in heart failure:untying the Gordian knot显示文摘Atrial fibrillation(AF) and heart failure(HF) are complex clinical entities that occur concomitantly in a significant population of patients, and their prevalence is rising in epidemic proportions. Traditionally, both rate and rhythm control strategies have been regarded as equivalent in the management of dysrhythmia in this AF-HF cohort with escalation of treatment largely guided by symptoms. Both disorders are involved in an elaborate pathophysiological interplay with shared cardiovascular risk factors that contribute to the development and sustenance of both AF and HF. Recent studies and continued development of evidence to support catheter ablation for AF has brought into question the traditional belief in equivalence between rate and rhythm control. Indeed, recent trials, in particular the CASTLE-AF(Catheter Ablation versus Standard Conventional Therapy in Patients with Left Ventricular Dysfunction and Atrial Fibrillation) study, suggest that catheter ablation for AF improves survival and rates of hospitalisation in patients with concomitant HF and AF, threatening a paradigm shift in the management of this patient cohort. The evident mortality benefit from clinical trials suggests that catheter ablation for AF should be considered as a therapeutic intervention in all suitable patients with the AF-HF syndrome as these patients may derive the greatest benefit from restoration of sinus rhythm. Further research is needed to refine the evidence base, especially to determine which subgroup of HF patients benefit most from catheter ablation and what is the optimal timing.	Saad Javed Ioanna Koniari David Fox Chris Skene Gregory YH Lip Dhiraj Gupta	2021	Journal of Geriatric Cardiology2021，18，4：	1
	6	Molecular mechanisms of cholesterol absorption and transport in the intestine 显示文摘	David YH Philip NH	2005	Seminars in Cell & Developmental Biology2005，16，：	1
	7	Prevalence of sleep disturbances in Chinese patients with End Stage Renal Failure on maintenance hemodialysis显示文摘	David SCH Teresa YH Thomas Li	2002	Med Sci Monit2002，8，5：	1
	8	Prevalence of sleep dist urbances in Chinese patient s with end stag e renal failure on ma intenance hemo dialysis显示文摘	David SCH T eresa YH T homas L		0，，：	1
	9	Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial显示文摘	Jonathan Mant FD Richard Hobbs Kate Fletcher Andrea Roalfe David Fitzmaurice Gregory YH Lip Ellen Murray	2007	The Lancet . 2007 (9586)2007，，：	1
	10	Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis显示文摘	David SCH Teresa YH Thomas L	2002	Med Sci Monit2002，8，5：	1
	11	Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fi brillation(the Birmingham Atrial Fibrillation Treatment of the Aged Study,BAFTA):a randomised controlled trial显示文摘	Jonathan Mant FD Richard Hobbs Kate Fletcher Andrea Roalfe David Fitzmaurice Gregory YH Lip Ellen Murray	2007	Lancet2007，370，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费